Piedmont Investment Advisors’s Charles River Laboratories CRL Stock Holding History

Piedmont Investment Advisors’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-7,889	Closed	-$996K	–	151
2020 Q1	$996K	Buy	7,889 +608	+8%	+$91.2K	0.04%	306
2019 Q4	$1.11M	Sell	7,281 -623	-8%	-$86.3K	0.04%	314
2019 Q3	$1.05M	Sell	7,904 -295	-4%	-$39.6K	0.04%	307
2019 Q2	$1.16M	Buy	8,199 +4,419	+117%	+$599K	0.05%	292
2019 Q1	$549K	Buy	3,780 +50	+1%	+$6.57K	0.02%	495
2018 Q4	$422K	Buy	3,730 +1,272	+52%	+$159K	0.02%	530
2018 Q3	$331K	Buy	2,458 +2,453	+49,060%	+$303K	0.01%	737
2018 Q2	$1K	Buy	+5	New	+$541	﹤0.01%	2743
2016 Q2	–	Sell	-27	Closed	-$2.05K	–	644
2016 Q1	$2.05K	Hold	27	–	–	﹤0.01%	323
2015 Q4	$2.17K	Hold	27	–	–	﹤0.01%	320
2015 Q3	$1.72K	Hold	27	–	–	﹤0.01%	349
2015 Q2	$1.9K	Hold	27	–	–	﹤0.01%	352
2015 Q1	$2.14K	Sell	27 -3	-10%	-$221	﹤0.01%	251
2014 Q4	$1.91K	Buy	30 +11	+58%	+$690	﹤0.01%	266
2014 Q3	$1.14K	Sell	19 -29	-60%	-$1.66K	﹤0.01%	297
2014 Q2	$2.57K	Buy	+48	New	+$2.63K	﹤0.01%	255

Other funds holding CRL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Piedmont Investment Advisors's CRL Position: Q2 2020 in Review

Piedmont Investment Advisors sold out of Charles River Laboratories (CRL) in Q2 2020, closing a stake of 7,889 shares — an estimated $996K sold.

Piedmont Investment Advisors first reported a position in CRL in Q2 2014 and held it in 16 quarters. The position peaked at $1.16M in Q2 2019. 466 funds tracked by Wall St. Rank hold CRL as of Q2 2020.

Piedmont Investment Advisors reported no remaining Charles River Laboratories position as of Q2 2020 after selling out during the quarter.
Piedmont Investment Advisors sold 7,889 Charles River Laboratories shares in Q2 2020, an estimated $996K.
Piedmont Investment Advisors first reported a position in Charles River Laboratories in Q2 2014 and held it in 16 quarters.
Piedmont Investment Advisors's Charles River Laboratories position peaked at $1.16M in Q2 2019.
466 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2020.

Based on Piedmont Investment Advisors's 13F filing for Q2 2020.